The biggest U.S. gasoline price surge in years is running out of steam just in time for the start of the summer driving season.Energyread more
Stocks rose on Friday, but notched weekly losses as investors worried the U.S.-China trade war is hurting economic growth.US Marketsread more
The combination of mounting recession fears, bets on a more cautious Fed and a regular uptick in market volatility could spell more losses.Marketsread more
The therapy, Zolgensma, is a one-time treatment for spinal muscular atrophy — a muscle-wasting disease and leading genetic cause of infant mortality, affecting 1 in every...Biotech and Pharmaceuticalsread more
SpaceX has raised just over $1 billion in financing since the beginning of the year.Investing in Spaceread more
An analyst for Ark Invest, which has a major investment in Tesla, says recent drastic price-target cuts by others on Wall Street are missing the big picture.Investingread more
Former Foreign Minister Boris Johnson is seen as the bookmaker's favorite to succeed outgoing Prime Minister Theresa May.Europe Politicsread more
Apple bought Tueo Health, which was developing tech to help parents monitor asthma symptoms in children, using a mobile app and commercial breathing sensors.Technologyread more
United Airlines will take its 14 Boeing 737 Max jets off its schedule for another month, through Aug. 3, canceling another 1,290 flights.Airlinesread more
Trade could be a big factor for markets in the week ahead, but investors will also be attuned to fresh inflation data and the bond market, which is flashing new worries about...Market Insiderread more
Mississippi is one of several states that have moved to pass new restrictions on abortion this year.Politicsread more
Check out the companies making headlines after the bell:
Shares of Gilead dropped as much as 5 percent after hours after the biotech company released disappointing test results from one of its chronic liver disease drugs. The company said it was "disappointed" the study did not achieve its goal but they "remain committed to advancing therapies for patients."
Shares of RingCentral rose as much as 6 percent in extended trading Monday following the release of their fourth quarter earnings. Revenue was $188.6 million, beating estimates of $181.1 million. Earnings per share were 23 cents, compared to the 18 cents that analysts expected. The company gave strong 2019 revenue guidance and 2019 earnings per share guidance were largely above estimates.
Chegg shares surged as much as 10 percent after hours on Monday following an earnings beat. The educational technology company beat on the top and bottom lines. Earnings per share were 25 cents, beating estimates by 4 cents. Revenue was $95.7 million, vs. the forecast $91.7 million. The company issued strong guidance for this quarter and 2019. The stock has more than doubled its value over the past year.
Amkor Technology shares dropped more than 5 percent in extended trading Monday based on weak first-quarter sales guidance despite better-than-expected earnings. The apple-supplier reported earnings of 19 cents per share on revenues of $1.08 billion. Analysts expected earnings per share of 8 cents on revenues of $1.06 billion. The company said weak sales guidance reflects an inventory correction currently underway in the smart-phone market.